Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies

References

• Adeloye D, Chua S, Lee C., et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05-020415
   PubMed Web of Science ®Google Scholar
• Blanco I, Diego I, Bueno P, et al. Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique. Int J Chron Obstruct Pulmon Dis. 2018;13:57–67. doi:10.2147/copd.S150853
   PubMed Web of Science ®Google Scholar
• Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4. doi:10.1017/gheg.2018.1
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Global Initiative for Chronic Obstructive Lung Disease (GOLD).
   Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): a Systematic Literature Review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/copd.S234942
   PubMed Web of Science ®Google Scholar
• May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36(1):4–10. doi:10.2500/aap.2015.36.3812
   PubMed Web of Science ®Google Scholar
• Polverino F, Celli B. The Challenge of Controlling the COPD Epidemic: unmet Needs. Am J Med. 2018;131(9):1–6. doi:10.1016/j.amjmed.2018.05.001
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/copd.S139470
   PubMed Web of Science ®Google Scholar
• Cook NS, Kostikas K, Gruenberger J-B, et al. Patients’ perspectives on COPD: findings from a social media listening study. ERJ Open Res. 2019;5(1):00128–2018. doi:10.1183/23120541.00128-2018
   PubMedGoogle Scholar
• Cook N, Gey J, Oezel B, et al. Impact of cough and mucus on COPD patients: primary insights from an exploratory study with an Online Patient Community. Int J Chron Obstruct Pulmon Dis. 2019;14:1365–1376. doi:10.2147/COPD.S202580
   PubMed Web of Science ®Google Scholar
• Patalano F, Gutzwiller FS, Shah B, Kumari C, Cook NS. Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: patient-Centric Drug Development from Theory to Practice. Adv Ther. 2020;37(1):17–26. doi:10.1007/s12325-019-01134-x
   PubMed Web of Science ®Google Scholar
• Crawford B, Monz B, Hohlfeld J, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545–1555. doi:10.1016/j.rmed.2008.06.009
   PubMed Web of Science ®Google Scholar
• US. FDA. 2006D-0044: guidance for Industry on Patient-Reported Outcome Measures: use in Medical Product Development to Support Labeling Claims; 2006.
   Google Scholar
• Monz BU, Sachs P, McDonald J, Crawford B, Nivens MC, Tetzlaff K. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. Respir Med. 2010;104(4):534–541. doi:10.1016/j.rmed.2009.10.026
   PubMed Web of Science ®Google Scholar
• Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Value Health. 2009;12(8):1075–1083. doi:10.1111/j.1524-4733.2009.00603.x
   PubMed Web of Science ®Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–977. doi:10.1016/j.jval.2011.06.014
   PubMed Web of Science ®Google Scholar
• Rothman M, Gnanaskathy A, Wicks P, Papadopoulos EJ. Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development? Value Health. 2015;18(1):1–4. doi:10.1016/j.jval.2014.10.001
   PubMed Web of Science ®Google Scholar
• Goossens LMA, Nivens MC, Sachs P, Monz BU, Rutten-van Mölken MP. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? Respir Med. 2011;105(8):1195–1202. doi:10.1016/j.rmed.2011.02.018
   PubMed Web of Science ®Google Scholar
• Kirishi S, Kubo A, Okabayashi A, et al. Efficacy of Once-Daily QVA149 Compared with Tiotropium Plus Theophylline in Symptomatic Patients with Moderate to Severe COPD. presented at: D36 All Together Now: copd Treatment With Long-Acting Beta Agonists And Long-Acting Muscarinic Antagonists. The Journal of Asthma: Official Journal of the Association for the Care of Asthma. 2015;52(5):512–518. doi:10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5738
   PubMedGoogle Scholar
• Siler TM, Nagai A, Scott-Wilson CA, Midwinter D, Crim C. A randomised, Phase III trial of once-daily fluticasone furoate/vilanterol 100/25ug versus once-daily vilanterol 25ug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD. Respir Med. 2017;123:8–17. doi:10.1016/j.rmed.2016.12.001
   PubMed Web of Science ®Google Scholar
• Tagaya E, Yagi O, Sato A, et al. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther. 2016;39:81–84. doi:10.1016/j.pupt.2016.06.008
   PubMed Web of Science ®Google Scholar
• Rebelo P, Oliveira A, Paixão C, Valente C, Andrade L, Marques A. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:201–212. doi:10.2147/copd.s219480
   PubMed Web of Science ®Google Scholar
• Bennett WD, Henderson AG, Ceppe A, et al. Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis. ERJ Open Res. 2020;6(3):00269–2020. doi:10.1183/23120541.00269-2020
   PubMedGoogle Scholar
• Deslee G, Burgel P-R, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2091–2097. doi:10.2147/copd.s106883
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Sato S, Tanimura K, et al. Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease. Respir Investig. 2018;56(3):230–237. doi:10.1016/j.resinv.2018.01.001
   PubMed Web of Science ®Google Scholar
• Boehringer, Ingelheim. Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease; 2015.
   Google Scholar